Logo

synthetic oligonucleotides

Twist Bioscience Raises FY2023 Revenue Guidance on Higher NGS Sales

The revised expectations came as the firm reported 14 percent growth in fiscal Q3 revenues, beating Wall Street estimates on the top and bottom lines.  

Atantares Closes Early Financing Rounds, Raising RMB 100M

The Beijing-based firm is developing semiconductor chips for use in biotechnology, including high-throughput DNA synthesis.

Camena Bioscience Closes $10M Series A Financing Round

The UK-based synthetic biology startup said it will use the funding to scale its operations and to further develop its gSynth enzymatic DNA synthesis platform.

Synthetic DNA Startup Elegen Gains Traction With Customers, Funders
Premium

The Bay Area company counts Ginkgo Bioworks among its customers for synthetic DNA molecules between 1 Kb and 7 Kb long.

EnPlusOne Biosciences Nabs Exclusive License to RNA Synthesis Technology from Wyss Institute

EnPlusOne Bio has secured a worldwide license to the ezRNA platform developed in the lab of George Church, one of the firm's cofounders.

Dec 7, 2022

GenScript, Allozymes Partner on Enzyme Discovery and Development Services

Oct 17, 2022

Wayfinder Biosciences Raises $3.5M in Seed Funding

Oct 14, 2022

EnPlusOne Biosciences on Path Towards Commercial Enzymatic RNA Synthesis
Premium

Sep 30, 2022

Enzymatic RNA Synthesis Firm EnPlusOne Biosciences Launches With $12M in Seed Funding

Aug 5, 2022

Twist Bioscience Raises Full-Year Revenue Guidance After Fiscal Q3 Revenues Rise 60 Percent

Apr 26, 2022

RootPath Brings Collaborators Into the Fold With Origami-Based Synthetic DNA Assembly Method
Premium

Apr 20, 2022

Ansa Biotechnologies Accelerating Enzymatic DNA Synthesis Technology as a Commercial Service
Premium

Apr 18, 2022

Startups Emerge at SynBio Conference Offering Longer, Purer Synthetic DNA
Premium

Apr 14, 2022

GenScript Jumps Into DNA Data Storage Market With New Synthesis Platform
Premium

Apr 5, 2022

Twist Bioscience, Ginkgo Bioworks Sign New Synthetic DNA Supply Agreement

Jan 28, 2022

Maravai LifeSciences Acquires Nucleotide Maker MyChem for at Least $240M

Nov 30, 2021

DNA Script Receives CE Mark for Syntax Enzymatic DNA Synthesis Platform

Nov 9, 2021

DNA Script on Track for Release of Enzymatic DNA Synthesis Platform in 2022
Premium

Nov 4, 2021

Codexis, Casdin Capital Invest $10M in Molecular Assemblies

Oct 26, 2021

DNA Script Raises $165M in Series C Funding Round

Aug 18, 2021

Researchers Call for Investment in Direct RNA Sequencing
Premium

Aug 6, 2021

Twist Bioscience Fiscal Q3 Revenues Grow 65 Percent

Jul 14, 2021

Sci-Space Method Ties Single-Cell Gene Expression Differences to Spatial Context
Premium

Jun 23, 2021

Codex DNA Closes $122.7M IPO

Apr 15, 2021

Molecular Assemblies Extends Series A Financing Round by $11.8M

Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.